Pentigetide forms a compact peptide sequence that supports modeling of hydrophobic-polar balance in ligand systems. The motif aids exploration of folding and binding determinants. Researchers evaluate its dynamic conformations across environments. Uses include peptide optimization, structural studies, and binding-site mapping.
CAT No: R2465
CAS No:62087-72-3
Synonyms/Alias:Pentigetide;Pentyde;62087-72-3;Hamburger Pentapeptide;human ige pentapeptide;Pentigetida;Pentigetidum;Pentigetid;ASP-SER-ASP-PRO-ARG;HEPP;IGE PENTAPEPTIDE;Pentigide;Pentyde (TN);PENTAPEPTIDE DSDPR;Pentigetide (USAN/INN);YG3J18T1UX;(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid;HEP-P;Pentigetide [USAN:INN];Pentigetidum [INN-Latin];UNII-YG3J18T1UX;Pentigetida [INN-Spanish];PENTAPEPTIDE-DSDPR;PENTIGETIDE [MI];PENTIGETIDE [INN];PENTIGETIDE [USAN];SCHEMBL29861;Aspartylserylaspartylprolylarginine;DTXSID30977675;CHEBI:135842;KQDIGHIVUUADBZ-PEDHHIEDSA-N;HY-P3746;N(sup 2)-(1-(N-(N-L-alpha-Aspartyl-L-seryl)-L-alpha-aspartyl)-L-prolyl)-L-arginine;CS-0620399;NS00122940;D05423;L-Aspartyl-L-Seryl-L-Aspartyl-L-Prolyl-L-Arginine;Q27294502;L-.ALPHA.-ASPARTYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-PROLYL-L-ARGININE;L-Arginine, N(sup 2)-(1-(N-(N-L-alpha-aspartyl-L-seryl)-L-alpha-aspartyl)-L-prolyl)-;(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-5-[(diaminomethylidene)amino]pentanoic acid;(S)-2-((S)-1-((S)-2-((S)-2-((S)-2-amino-3-carboxypropanamido)-3-hydroxypropanamido)-3-carboxypropanoyl)pyrrolidine-2-carboxamido)-5-guanidinopentanoic acid;L-ARGININE, N(SUP 2)-(1-(N-(N-L-.ALPHA.-ASPARTYL-L-SERYL)-L-.ALPHA.-ASPARTYL)-L-PROLYL)-;N(SUP 2)-(1-(N-(N-L-.ALPHA.-ASPARTYL-L-SERYL)-L-.ALPHA.-ASPARTYL)-L-PROLYL)-L-ARGININE;N~2~-[{1-[2-({2-[(2-Amino-3-carboxy-1-hydroxypropylidene)amino]-1,3-dihydroxypropylidene}amino)-3-carboxypropanoyl]pyrrolidin-2-yl}(hydroxy)methylidene]arginine;
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More